Last Price
326.09
Today's Change
+11.13 (3.53%)
Day's Change
313.62 - 327.89
Trading Volume
364,943
Market Cap
10 Billion
Shares Outstanding
31 Million
Avg Volume
375,217
Avg Price (50 Days)
340.90
Avg Price (200 Days)
378.85
PE Ratio
28.53
EPS
11.43
Earnings Announcement
10-Feb-2025
Previous Close
314.96
Open
313.62
Day's Range
313.62 - 327.89
Year Range
268.795 - 459.77
Trading Volume
375,973
1 Day Change
3.53%
5 Day Change
-1.84%
1 Month Change
-7.60%
3 Month Change
-17.59%
6 Month Change
-17.79%
Ytd Change
6.71%
1 Year Change
18.03%
3 Year Change
47.83%
5 Year Change
336.30%
10 Year Change
1073.41%
Max Change
1073.41%
No result.
Sector: Healthcare - Healthcare
Industry: Diagnostics & Research
Description:
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, it offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The company was founded in 1992 and is based in Cincinnati, Ohio.